ISSCR News
The ISSCR Joins Coalition Letter Supporting NIH Funding
The ISSCR joined 360 members of the Ad Hoc Group for Medical Research to share recommendations for National Institutes of Health (NIH) funding for 2022. The letter stresses the need for reliable annual funding support for the NIH a key national priority. The Ad Hoc Group for Medical Research represents patient groups, scientific societies, research and academic institutions, health professionals, educators, and industry,
Member Spotlight: Jihwan Song, D Phil
“I am excited about the possibility that the 10 HLA-homozygous induced pluripotent stem cell (iPSC) lines that we have recently established from frozen cord blood samples can cover more than 40% of the Korean population, and be used to treat diverse Asian populations”.
The ISSCR Urges HHS to Rescind the Proposed Rule on Human Fetal Tissue Research
94 Scientific, Medical, and Patient Organizations Sign-on to Comment LetterThe ISSCR has submitted comments urging the Department of Health and Human Services (HHS) to withdraw the proposed rule (RIN 0991-AC-15) on extramural research involving human fetal tissue (HFT). Among other key points, the letter states that the proposed rule would impede promising biomedical research that could lead to new treatments for serious diseases, including COVID-19.
A New Frontier
Message from the President, Christine MummeryWe are entering a new frontier of stem cell science and regenerative medicine. With it, comes new technology, insight, and greater biological understanding. So too, comes tough questions and challenges — ethics, regulation, equitable access to name a few.
Retinal Cell Transplant Clears Experimental Hurdle Toward Treating Blindness
Retinal cells derived from adult human eye stem cells survived when transplanted into the eyes of monkeys, an important early step in the validation of this approach for treating blindness, according to a study by Liu, et al recently published in Stem Cell Reports. The retinal pigment epithelium (RPE), a layer of pigmented cells in the retina, is essential for sustaining normal vision. Blindness due to RPE dysfunction, such as macular degeneration, affects about 200 million people worldwide.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .